The rising cost of Gilead’s Truvada may be a key factor in why the HIV prevention drug has not been widely used, according to an analysis published in the Annals of Internal Medicine. Truvada, also ...

When its U.S. patent cliff for HIV med Truvada was still on the horizon, Gilead Sciences won approval for follow-up med Descovy and launched an aggressive campaign to switch patients to the new drug.

Editor’s Note: This is the second part of a two-part series on PrEP. Ask a group of gay men what they think of Truvada, and you’re likely to get a response that goes something like this: “I don’t like ...

Descovy demonstrated continued noninferiority to Truvada for HIV pre-exposure prophylaxis and statistically significant differences over Truvada for pre-specified secondary end points. In the phase 3, ...

Add Yahoo as a preferred source to see more of our stories on Google. Gilead will be offering free pre-exposure prophylaxis (PrEP) in a new partnership with the Centers for Disease Control and ...

Consumer Reports has no financial relationship with advertisers on this site. About 38,000 Americans develop HIV each year, according to the Centers for Disease Control and Prevention. Two ...

A long-awaited generic version of Truvada, used for both HIV treatment and PrEP, went on the market Friday, October 2. But the wholesale cost of the new pill from Teva Pharmaceuticals – about $1,455 – ...

COLUMBUS (WCMH) — Life saving for those living with HIV, disease preventing for those at high risk for contracting it, a dual use drug that both treats and prevents HIV is at the center of multiple ...

Gilead Sciences will give free Truvada pills to 200,000 uninsured people for the next 11 years to help prevent new HIV infections, the pharmaceutical company said Thursday. The announcement of the ...